Trials / Recruiting
RecruitingNCT05743049
Collection of Circulating Biomarkers in Pancreatic Cancer
Protocol to Permit Collection of Circulating Biomarkers in Pancreatic Cancer
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This protocol will involve collection of blood samples from patients with a diagnosis of pancreatic adenocarcinoma for evaluation of circulating biomarkers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Obtaining blood for analysis of various circulating biomarkers | 4 tbsp of blood in a 1-week period, occurring no more frequently than 4 times in an 8-week period |
Timeline
- Start date
- 2023-02-27
- Primary completion
- 2027-06-30
- Completion
- 2028-01-15
- First posted
- 2023-02-24
- Last updated
- 2026-04-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05743049. Inclusion in this directory is not an endorsement.